JP2025503442A5 - - Google Patents

Info

Publication number
JP2025503442A5
JP2025503442A5 JP2024535947A JP2024535947A JP2025503442A5 JP 2025503442 A5 JP2025503442 A5 JP 2025503442A5 JP 2024535947 A JP2024535947 A JP 2024535947A JP 2024535947 A JP2024535947 A JP 2024535947A JP 2025503442 A5 JP2025503442 A5 JP 2025503442A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
halo
alkynyl
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024535947A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025503442A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081522 external-priority patent/WO2023114824A1/en
Publication of JP2025503442A publication Critical patent/JP2025503442A/ja
Publication of JP2025503442A5 publication Critical patent/JP2025503442A5/ja
Pending legal-status Critical Current

Links

JP2024535947A 2021-12-15 2022-12-14 ビシクロ［３．２．０］ヘプタンビス（アミド）ｒｘｆｐ１アゴニスト Pending JP2025503442A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163289859P 2021-12-15 2021-12-15
US63/289,859 2021-12-15
PCT/US2022/081522 WO2023114824A1 (en) 2021-12-15 2022-12-14 Bicyclo [3.2.0] heptane bis(amide) rxfp1 agonists

Publications (2)

Publication Number Publication Date
JP2025503442A JP2025503442A (ja) 2025-02-04
JP2025503442A5 true JP2025503442A5 (cg-RX-API-DMAC7.html) 2025-12-23

Family

ID=85278161

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024535947A Pending JP2025503442A (ja) 2021-12-15 2022-12-14 ビシクロ［３．２．０］ヘプタンビス（アミド）ｒｘｆｐ１アゴニスト

Country Status (6)

Country Link
US (1) US20250049765A1 (cg-RX-API-DMAC7.html)
EP (1) EP4448483A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025503442A (cg-RX-API-DMAC7.html)
KR (1) KR20240122835A (cg-RX-API-DMAC7.html)
CN (1) CN118434712A (cg-RX-API-DMAC7.html)
WO (1) WO2023114824A1 (cg-RX-API-DMAC7.html)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1614676A4 (en) * 2003-03-27 2009-03-25 Kirin Pharma Kk CONNECTION TO INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICAMENT CONTAINING THEREOF
US9452973B2 (en) * 2012-05-04 2016-09-27 The United States Of America, As Represented By The Secretary Department Of Health And Human Services Modulators of the relaxin receptor 1

Similar Documents

Publication Publication Date Title
JP2024540164A5 (cg-RX-API-DMAC7.html)
US10941113B2 (en) Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
JP2024516033A5 (cg-RX-API-DMAC7.html)
JP2024540163A5 (cg-RX-API-DMAC7.html)
JP3558088B2 (ja) トロポン−置換のフェニルオキサゾリジノン抗菌剤
JP2021534106A5 (cg-RX-API-DMAC7.html)
JP2024543475A5 (cg-RX-API-DMAC7.html)
JP2021514001A5 (cg-RX-API-DMAC7.html)
JP2024518555A5 (cg-RX-API-DMAC7.html)
CN105669751B (zh) 非环核苷酸磷酰胺类化合物及其盐的制备以及在抗病毒方面的应用
JPH02218685A (ja) 保護されたカルボキシ基を有するセフェム化合物およびその製造法
JP2025501509A5 (cg-RX-API-DMAC7.html)
JP2021535174A5 (cg-RX-API-DMAC7.html)
JP2023544476A5 (cg-RX-API-DMAC7.html)
JP2020507589A5 (cg-RX-API-DMAC7.html)
JP2009524691A5 (cg-RX-API-DMAC7.html)
JP2024518791A5 (cg-RX-API-DMAC7.html)
JP2011502986A (ja) 重水素化フィンゴリモド
JP2020111571A5 (cg-RX-API-DMAC7.html)
JP2025503442A5 (cg-RX-API-DMAC7.html)
JP2024546946A5 (cg-RX-API-DMAC7.html)
JP2022529806A5 (cg-RX-API-DMAC7.html)
JP2025507292A5 (cg-RX-API-DMAC7.html)
JP2024540161A5 (cg-RX-API-DMAC7.html)
RU2380361C2 (ru) Способ получения производных 1,4-дифенилазетидинона